Skip to main content
. Author manuscript; available in PMC: 2017 Dec 12.
Published in final edited form as: J Scleroderma Relat Disord. 2016 Jul 23;1(2):177–240. doi: 10.5301/jsrd.5000209

TABLE I.

Demographic features, classification and environmental exposures in female and male SSc patients

Females (n = 2144) Males (n = 542) Significance (p value)
n (%) n (%) Unadjusted Adjusteda
Race
 Caucasian (%) 1929 (90%) 488 (90%) NS NS
Age (mean years ± SD)
 Age at symptom onset 43.8 ± 14.0 46.4 ± 13.7 <0.001 0.0017
 Age at SSc diagnosis 48.7 ± 13.6 49.8 ± 13.1 NS NS
 Age at first Pittsburgh visit 51.8 ± 13.4 51.8 ± 12.9 NS NS
Disease duration (years), median [interquartile range]
 Onset to first Pittsburgh visit 3.9 [10.4] 2.3 [5.0] <0.0001 0.0005
 First Pittsburgh visit to last clinical follow-up 7.7 [11.0] 5.9 [9.4] <0.0001 <0.0001
Residence [within 100 miles of Pittsburgh; referral area], n (%) 1053 (49%) 276 (51%) NS NS
Disease classification, n (%)
 Diffuse cutaneous 794 (37%) 262 (48%) <0.0001 <0.0001
 Limited cutaneous 1142 (53%) 232 (43%)
 Overlap syndrome 208 (10%) 48 (9%) 0.0008 0.0008
  Diffuse 60 (29%) 20 (42%)
  Limited 148 (71%) 28 (58%)
 Overlap types
  SSc, SLE 56 (27%) 2 (4%)
  SSc, myositis 119 (57%) 42 (88%)
  SSc, RA 16 (8%) 2 (4%)
  SSc, SLE, myositis 14 (7%) 2 (4%)
  SSc, RA, myositis 3 (1%) 0 (0%)
Environmental exposures, n (%)
 Cigarette smoking (ever) 903 (42%) 338 (63%) <0.0001 <0.0001
 Occupational 48 (11%) 58 (49%) <0.0001 <0.0001
a

Adjusted for cutaneous subtype (dc, lc).

SSc = systemic sclerosis; dc = diffuse cutaneous; lc = limited cutaneous; SLE = systemic lupus erythematosus; SD = standard deviation; RA = rheumatoid arthritis; NS = non-significant.